---
abstract: Pathogenesis of ependymomas is still poorly understood and molecular markers
  for risk-adapted patient stratification are not available. Our aim was to screen
  for novel genomic imbalances and prognostic markers in ependymal tumors.
authors: Mendrzyk F, Korshunov A, Benner A, Toedt G, Pfister S, Radlwimmer B and Lichter
  P.
cancertypes:
- samples_arraymap: 68
  samples_progenetix: ~
  term_id: ncit:C6903
  term_label: Tanycytic Ependymoma
- samples_arraymap: 68
  samples_progenetix: ~
  term_id: pgx:icdom:9391_3
  term_label: Ependymoma, NOS
- samples_arraymap: 68
  samples_progenetix: ~
  term_id: pgx:icdot:C71.9
  term_label: Brain, NOS
- samples_arraymap: 68
  samples_progenetix: ~
  term_id: pgx:seer:31010
  term_label: Brain
- samples_arraymap: 68
  samples_progenetix: ~
  term_id: snmi:M-93913
  term_label: Ependymoma, NOS
contact:
  email: m.macleod@dkfz.de
  name: Peter Lichter
counts:
  biosamples: 68
  samples_acgh: 68
  samples_ccgh: 0
  samples_wes: 0
  samples_wgs: 0
external_identifiers:
- pubmed:16609018
- geo:GSE3435
geo_data:
  geo_json:
    coordinates:
    - 8.69
    - 49.41
    type: Point
  info:
    city: Heidelberg
    continent: Europe
    country: Germany
    label: Heidelberg, Germany, Europe
    precision: city
journal: 'Clin Cancer Res 12, 7 Pt 1 (2006): 2070-79.'
label: 'Mendrzyk et al. (2006): Identification of Gains on 1q and Epidermal Growth
  Factor Receptor Overexpression as Independent ...'
notes: ~
pmid: 16609018
title: Identification of Gains on 1q and Epidermal Growth Factor Receptor Overexpression
  as Independent Prognostic Markers in Intracranial Ependymoma.
year: 2006
